When a Follicle Doesn't Rupture: LUFS and Fertility

You tracked the cycle. The scan showed a lead follicle at 21 mm. The ovulation test turned positive, the temperature shifted, and a week later progesterone came back in a reassuring range. On paper you ovulated. But the follicle never opened, the egg was never released, and the cycle was never going to work.

That is a luteinized unruptured follicle — LUF, or luteinized unruptured follicle syndrome (LUFS). It is one of the few fertility problems that hides behind normal test results, which is exactly why it gets missed in cycles labeled unexplained.

What is a luteinized unruptured follicle?

A luteinized unruptured follicle is a follicle that receives the LH surge and turns into a functioning corpus luteum — producing progesterone, shifting your temperature, building a secretory lining — without rupturing and releasing the egg. The hormonal half of ovulation happens. The mechanical half does not.

It was first described in 1978, when Marik and Hulka took 102 women with infertility to laparoscopy three to five days after what looked like ovulation. Thirty had no corpus hemorrhagicum at all, and another 32 had one with no rupture site on it — physical evidence in 62 women that a follicle had luteinized without letting the egg out, despite biphasic temperature curves, secretory endometrium and elevated progesterone.

Rupture is not a passive pop. The LH surge sets off a local, inflammation-like cascade inside the follicle — prostaglandins, EGF-like growth factors, proteolytic enzymes that digest the follicle wall at one targeted spot, and vascular remodeling — summarized in a 2025 Human Reproduction Update review of human ovulation. Any step in that cascade can fail while the steroid-producing step succeeds.

Why do progesterone, ovulation tests and temperature all look normal?

Because every one of those markers measures luteinization, not release. An ovulation predictor kit reads the LH surge, which happens in a LUF cycle. Basal body temperature reads the progesterone rise, which also happens. A 7 DPO progesterone draw reads the corpus luteum's output, and a luteinized follicle is a corpus luteum in everything but the hole it should have made.

In Kerin's classic monitoring study, LUF follicles behaved steroidogenically like a normal corpus luteum and the luteal phase ran a normal length. Hamilton's series of 600 monitored cycles found the same thing with one useful detail: in LUF cycles the LH peak and midluteal progesterone were significantly lower than in ovulatory cycles, and after the LH peak the follicle kept growing instead of collapsing. So progesterone in a LUF cycle is often not zero and not clearly abnormal — just quietly lower. That is the pattern we see in patients told their 7 DPO progesterone was borderline and to try again next month.

This is the practical point: a progesterone rise confirms luteinization, not egg release. Only imaging — seeing the follicle collapse, or seeing it persist and grow — distinguishes the two. It is the same problem we describe in signs of poor ovulation, where regular bleeding gets read as proof of a good ovulatory event.

How often does a follicle fail to rupture?

The honest answer depends entirely on who is being scanned and in what kind of cycle.

In healthy, regularly cycling women monitored by daily ultrasound, it is uncommon: 9 of 183 cycles, about 4.9%, in Kerin's 66-woman study, and it rarely repeated. In women with unexplained infertility scanned in their first monitored cycle, the numbers are similar — 9% of 33 patients in Daly's series, 4% of 250 women in Kugu's.

Stimulated cycles are a different story. Qublan's study followed 167 women with unexplained infertility through 292 clomiphene-plus-IUI cycles with ultrasound confirmation of rupture. LUF appeared in 25% in the first cycle, 56.5% in the second and 58.9% in the third, with recurrence rates of 78.6% and 90% in women who had already had one LUF cycle. No pregnancies occurred in any LUF cycle in that study.

So the figure worth remembering is not a single prevalence number. It is a direction: roughly 5% of natural cycles in fertile women, under 10% of first monitored cycles in unexplained infertility, and up to about a quarter of first stimulated IUI cycles rising toward 60% by the third — in a population selected for repeated failure and strongly prone to recurrence. If two IUIs have failed, the chance that rupture is the problem is no longer small.

Why would ovulation stimulation make this more likely, not less?

This is the part that surprises people. Drugs are given to force ovulation, and the same drugs can make the failure they were meant to fix more likely.

Three mechanisms show up in the data. First, the drug choice. In a randomized trial of 180 women undergoing IUI, letrozole with hMG produced significantly less LUF and more pregnancies than clomiphene with hMG. Clomiphene's anti-estrogenic effect on the hypothalamus and on the follicle itself is a plausible reason, and Check's earlier work found clomiphene corrected LUF in only 12% of patients versus 95% with hMG.

Second, follicle size at trigger. In that same trial, follicles of 22 mm or larger at hCG were associated with more LUF than follicles of 18–19.9 mm or 20–21.9 mm. A follicle allowed to grow too big before the trigger can become a follicle that luteinizes in place. Our post on letrozole and early ovulation covers the mirror-image timing problem.

Third, the trigger itself. In a prospective study of 513 clomiphene/IUI cycles in women with follicular-endometrial asynchrony, cancellation for a luteinized unruptured follicle was significantly more frequent with an hCG trigger than with a GnRH-agonist trigger, and clinical pregnancies were higher in the agonist group (10.33% vs 4.96%). An hCG trigger substitutes for the LH surge but does not reproduce its shape.

None of these are things to change on your own. They are the questions to bring to the clinician running your IUI or IVF cycle: what size were we at trigger, what did the post-trigger scan show, and does the protocol need to change rather than repeat.

Which hormones interfere with follicle rupture?

Rupture depends on the amplitude and shape of the LH surge and on the follicle's ability to respond to it. Several hormonal patterns can degrade either side.

A weak LH surge. Hamilton's LUF cycles had significantly lower LH peaks than ovulatory controls. A surge large enough to luteinize the granulosa cells is not automatically large enough to complete proteolysis of the follicle wall.

Prolactin. Kugu's LUFS group showed an exaggerated prolactin response to TRH compared with ovulatory controls, alongside lower midluteal progesterone — suggesting aberrant prolactin release as a contributor rather than an incidental finding. This is one reason we look at prolactin as a pattern over time rather than one number, as in elevated prolactin and fertility.

Thyroid. Low thyroid hormone raises TRH, which raises prolactin, and thyroid dysfunction independently disturbs the ovulatory signal. A single TSH is not a thyroid evaluation; the reasoning is in thyroid issues and infertility.

Androgens and premature luteinization. Check described two distinct patterns in 355 infertile women: mature-follicle LUF, where a fully grown follicle never releases, and premature-luteinization LUF, where progesterone rises above 2.5 ng/mL before the follicle has matured. The second pattern matters for anyone with PCOS physiology, where LH dynamics and androgen exposure are already altered — see PCOS ovulation problems.

Do metabolic factors change whether a follicle opens?

Rupture is an energy-expensive, enzyme-driven, vascular event, so metabolic conditions plausibly matter — but be careful how strongly anyone states this. There is no trial showing that fixing insulin resistance fixes LUF. What is established is that ovulation requires coordinated prostaglandin synthesis, matrix-degrading enzymes and blood-flow changes at the follicle wall, and that insulin resistance, chronic inflammation and oxidative stress alter exactly those systems elsewhere in the body.

That is why our work on a cycle like this runs on the three fertility dials — hormonal signaling, metabolic and vascular supply, and inflammatory or immune load — instead of a single lab value. Practically, it means addressing insulin resistance and inflammatory load as conditions the ovulatory cascade has to work inside, while stating plainly that the rupture evidence for those interventions is mechanistic, not proven in outcome trials.

One acupuncture-specific note, with its limits attached: a 2025 systematic review in Frontiers in Endocrinology pooled 15 randomized trials of 1,030 women with LUFS and reported higher ovulation rates, higher LH, estradiol and progesterone, and lower ovarian-artery resistance and pulsatility indices in the acupuncture groups. All 15 trials were conducted in China, most reported their methods poorly, and the authors say the findings may not generalize. We treat that as a reason to include acupuncture in a rupture-focused plan, not as evidence of a settled outcome.

Can a medication you are already taking stop a follicle from rupturing?

Yes, and this is the most actionable item on the page. Anti-inflammatory painkillers block the prostaglandin pathway that ovulation depends on. Morphological studies show COX-2 inhibition disrupts the targeted rupture of the follicle at its apex.

In women with inflammatory arthritis monitored by ultrasound, continuous NSAID exposure produced LUF in 35.6% of 59 cycles versus 3.4% in 449 unexposed cycles. Etoricoxib, a selective COX-2 inhibitor, accounted for most of those cases; ibuprofen at 1,600 mg/day did not induce LUF in that study, whether taken continuously around ovulation or intermittently.

If you take a prescription anti-inflammatory for a rheumatologic condition, do not stop it on your own — that decision belongs to the physician managing that disease, and untreated inflammatory disease carries its own reproductive cost. Bring the timing question to them: whether periovulatory dosing can be adjusted in the days around a trigger, and whether a different agent is reasonable while you are trying to conceive.

Does endometriosis stop follicles from rupturing?

Stage matters. Donnez looked for an ovulation ostium at luteal-phase laparoscopy in 100 fertile women and 118 women with endometriosis. An ostium was present in 91% of fertile women and 85% with mild endometriosis — but only 72% with moderate and 51% with severe endometriosis.

Adhesions, altered peritoneal fluid and a mechanically restricted ovarian surface all plausibly contribute. If endometriosis is known or suspected and IUIs are failing, a rupture-confirmation scan is worth more than another unmonitored cycle. We cover the wider picture in endometriosis and failed IVF and in severe endometriosis without pain.

How is LUFS actually diagnosed?

Only by imaging the follicle before and after the expected rupture. A single mid-luteal progesterone cannot do it, and neither can an ovulation kit.

The sequence your clinician can order is a pre-ovulatory scan documenting the lead follicle's size, then a repeat scan one to three days after the LH surge or trigger, looking for collapse of the follicle, free fluid, and the change in wall appearance. If the follicle is still there and has grown, with progesterone rising, that is the picture. Daly's series used serial scans at an average of 3.2 per cycle. Historically the finding was confirmed at laparoscopy by the absence of a rupture site, and older work added supportive endocrine clues — a slower post-ovulatory FSH decline, for example, consistent with follicular fluid never being released.

Two honest caveats. In fertile women it is usually a sporadic event, so one unruptured cycle is not a diagnosis of a syndrome. And a LUF cycle does not appear to compromise a frozen embryo transfer: in 144 LUF cycles versus 866 ovulatory cycles, implantation and pregnancy outcomes after FET were not significantly different. LUFS is a problem for conception that requires an egg to be released — natural cycles, IUI, timed intercourse — not a reason to cancel a frozen transfer.

What changes the odds in the next cycle?

Split it into what only your prescribing clinician can change and what belongs to the biological environment around the cycle.

Their side of the line: confirming rupture by ultrasound instead of assuming it; reconsidering clomiphene where letrozole is appropriate; triggering at a follicle size that has not overshot; considering a GnRH-agonist trigger where the history shows repeated unruptured follicles; evaluating prolactin, thyroid and androgens properly; and reviewing every anti-inflammatory and hormonal medication for periovulatory interference.

Our side: the metabolic, vascular and inflammatory conditions the ovulatory cascade runs inside, cycle-by-cycle tracking that distinguishes luteinization from release, and getting the history organized so a pattern across cycles is visible instead of one lab at a time. That is what a Fertility Roadmap is for, and it is how we approach unexplained infertility in patients across Long Island who have been told everything looks normal. The same logic applies before an insemination — see how to prepare for IUI.

When should you ask for a rupture-confirmation scan?

Raise it with your clinician if you have had two or more failed IUI cycles, unexplained infertility with apparently normal ovulation, cycles that look textbook on ovulation tests and temperatures with nothing happening, known moderate or severe endometriosis, continuous anti-inflammatory medication use, borderline luteal progesterone with regular cycles, or one documented unruptured follicle — because recurrence in the treated, infertile population is high.

Asking for one extra scan is a small request. Repeating a cycle that cannot work because the egg never left the ovary is the expensive option.

If you want help organizing what your cycles have actually shown — trigger sizes, post-trigger scans, luteal progesterone, medications — that is the conversation we have at our Huntington Station clinic. Start with a free 10-minute call or book a Metabolic & Immune Fertility Evaluation.

East to West Fertility is a metabolic and immune-focused fertility clinic in Huntington, Long Island, serving patients across Long Island, NYC, and beyond. Learn more about our Metabolic & Immune Fertility Evaluation or call 631-416-4940.

This article is for education and is not medical advice. East to West Fertility does not order or interpret diagnostic tests or prescribe medication; ultrasound monitoring, trigger protocols and prescriptions belong to your physician or reproductive endocrinologist.

References

1. Marik J, Hulka J. Luteinized unruptured follicle syndrome: a subtle cause of infertility. Fertil Steril. 1978;29(3):270–274. PMID 147778.
2. Kerin JF, Kirby C, Morris D, McEvoy M, Ward B, Cox LW. Incidence of the luteinized unruptured follicle phenomenon in cycling women. Fertil Steril. 1983;40(5):620–626. PMID 6628705.
3. Daly DC, Soto-Albors C, Walters C, Ying YK, Riddick DH. Ultrasonographic assessment of luteinized unruptured follicle syndrome in unexplained infertility. Fertil Steril. 1985;43(1):62–65. PMID 3917408.
4. Hamilton CJ, Wetzels LC, Evers JL, et al. Follicle growth curves and hormonal patterns in patients with the luteinized unruptured follicle syndrome. Fertil Steril. 1985;43(4):541–548. PMID 3921410.
5. Qublan H, Amarin Z, Nawasreh M, et al. Luteinized unruptured follicle syndrome: incidence and recurrence rate in infertile women with unexplained infertility undergoing intrauterine insemination. Hum Reprod. 2006;21(8):2110–2113. PMID 16613885.
6. Azmoodeh A, Pejman Manesh M, Akbari Asbagh F, Ghaseminejad A. Effects of letrozole-HMG and clomiphene-HMG on incidence of luteinized unruptured follicle syndrome in infertile women undergoing induction ovulation and intrauterine insemination: a randomised trial. Glob J Health Sci. 2015;8(3):244–252. PMID 26573024.
7. Bathwal S, Chakravarty A, Sharma S, et al. Efficacy of GnRH agonist trigger in women having history of follicular-endometrial asynchrony with clomiphene/IUI cycles in unexplained infertility. Arch Gynecol Obstet. 2018;298(2):427–432. PMID 29955952.
8. Check JH, Dietterich C, Nowroozi K, Wu CH. Comparison of various therapies for the luteinized unruptured follicle syndrome. Int J Fertil. 1992;37(1):33–40. PMID 1348733.
9. Micu MC, Micu R, Ostensen M. Luteinized unruptured follicle syndrome increased by inactive disease and selective cyclooxygenase 2 inhibitors in women with inflammatory arthropathies. Arthritis Care Res. 2011;63(9):1334–1338. PMID 21618455.
10. Gaytán M, Morales C, Bellido C, Sánchez-Criado JE, Gaytán F. Non-steroidal anti-inflammatory drugs (NSAIDs) and ovulation: lessons from morphology. Histol Histopathol. 2006;21(5):541–556. PMID 16493584.
11. Donnez J, Thomas K. Incidence of the luteinized unruptured follicle syndrome in fertile women and in women with endometriosis. Eur J Obstet Gynecol Reprod Biol. 1982;14(3):187–190. PMID 7160529.
12. Kugu K, Taketani Y, Kohda K, Mizuno M. Exaggerated prolactin response to thyrotropin-releasing hormone in infertile women with the luteinized unruptured follicle syndrome. Arch Gynecol Obstet. 1991;249(1):27–31. PMID 1909855.
13. Koninckx PR, Brosens IA, Verhoeven G, De Moor P. Increased postovulatory plasma follicle stimulating hormone levels in the luteinized unruptured follicle syndrome: a role for inhibin? Br J Obstet Gynaecol. 1981;88(5):525–529. PMID 6786323.
14. Wang L, Qiao J, Liu P, Lian Y. Effect of luteinized unruptured follicle cycles on clinical outcomes of frozen thawed embryo transfer in Chinese women. J Assist Reprod Genet. 2008;25(6):229–233. PMID 18566885.
15. Zhang R, Lin G, Wang W. Clinical evidence of acupuncture for luteinized unruptured follicle syndrome: a systematic review and meta-analysis of randomized controlled trials. Front Endocrinol. 2025;16:1640820. PMID 40951412.
16. Jo M, Brännström M, Akins JW, Curry TE. New insights into the ovulatory process in the human ovary. Hum Reprod Update. 2025;31(1):21–47. PMID 39331957.

If you want the clinic-side version of this — who should suspect it, what interferes with rupture, and what we can and cannot do about each piece — it is laid out on our luteinized unruptured follicle page.